Please login to the form below
D-day: time to make digital deliver
Chris Ross looks at why a platform-based, outcomes-focused approach could be key to demonstrating the value of digital health solutions
eConsent: Busting regulatory myths
‘eConsent improves the way consent is obtained, helps keep participants better informed and easily tracks study progress results’
Entering the era of digital trials
How technology is transforming the design, conduct and analysis of clinical research
Gradually, then suddenly
Company extinction is the result of cognitive shortcomings
Beneluxa: the future of European market access?
Andrew McConaghie talks to Beneluxa’s Marcel van Raaij and Biogen’s Erik Smet about their groundbreaking deal on Spinraza and what it means for European market access
Better together when buying medicines? Taking stock of the BeNeLuxA initiative
‘With Ireland being the latest to join in June 2018, there is clearly interest in the initiative that goes beyond the founding countries’
Digital Intelligence
Digital TrialsA framework for success
Safety first: AI adoption in the healthcare sectorAI's transformative impact on healthcare
The Editors
Jeux sans frontièresFrom regulations to customs, 2018 has some big questions to answer
Can NICE deliver on its funding promises?The Institute is now half-way thorugh its Cancer Drugs Fund reappraisals
Smart Thinking
Beneluxa: the future of European market access?Andrew McConaghie talks to Beneluxa’s Marcel van Raaij and Biogen’s Erik Smet about their groundbreaking deal on Spinraza and what it means for European market access
Better together when buying medicines? Taking stock of the BeNeLuxA initiative‘With Ireland being the latest to join in June 2018, there is clearly interest in the initiative that goes beyond the founding countries’
Darwin's Medicine
Gradually, then suddenlyCompany extinction is the result of cognitive shortcomings
- Generic Differentiation
Even in the cost-led market for generics, differentiated business models evolve
Ad Lib
Dig deep: turning emotion into actionLife's Reg Manser gives his take on three recent disease awareness campaigns for charities
Ads with biteJaw-dropping ads from around the world
Euro'vision
PRIME Time in the EUNew pathway promises expedited approvals for innovative medicines
- Europe's market access outlook
An ever-closer union?
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
-
Business Director
-
Competitive Salary Offered
-
Account Director
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Senior Account Manager
-
Competitive Salary Offered
-
Account Manager / Account Director
-
Competative
-
Associate Director
-
£75, 000-90, 000
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Global Business Development Director – Health Education
-
excellent commission
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
